Condition
G12D Mutated KRAS clinical trials and research
As of November 12, 2026, Find a Trial lists 2 G12D Mutated KRAS clinical trials that are recruiting, at sites in 6 countries (most in Australia (2), United States (2), France (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
KRAS G12D-mutated pancreatic cancer: VS-7375 with or without cetuximab
This study tests whether VS-7375, alone or with cetuximab, can help people with metastatic PDAC that carries the KRAS G12D mutation.
-
VS-7375 for adults with KRAS G12D-mutated advanced solid tumors.
This trial tests VS-7375, alone and combined with other cancer drugs, in adults with unresectable or metastatic solid tumors that have the KRAS G12D mutation.
Related topics
Quick answers
How many G12D Mutated KRAS clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Australia (2 trials), United States (2 trials), France (1 trial), Spain (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.